Axel Schlösser

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities

Abstract Background T cell-based immunotherapies have improved cancer treatment, however their efficacy is frequently limited by tumor-intrinsic resistance mechanisms and by the immune suppressive tumor microenvironment, counteracting tumor specific immune responses through impai...